The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis

På svenska

Author

  • Marieke G. M. Braem
  • N. Charlotte Onland-Moret
  • Leo J. Schouten
  • Anne Tjonneland
  • Louise Hansen
  • Christina C. Dahm
  • Kim Overvad
  • Annekatrin Lukanova
  • Laure Dossus
  • Anna Floegel
  • Heiner Boeing
  • Francoise Clavel-Chapelon
  • Nathalie Chabbert-Buffet
  • Guy Fagherazzi
  • Antonia Trichopoulou
  • Vassiliki Benetou
  • Ioulia Goufa
  • Valeria Pala
  • Rocco Galasso
  • Amalia Mattiello
  • Carlotta Sacerdote
  • Domenico Palli
  • Rosario Tumino
  • Inger T. Gram
  • Eiliv Lund
  • Oxana Gavrilyuk
  • Maria-Jose Sanchez
  • Ramon Quiros
  • Carlos A. Gonzales
  • Miren Dorronsoro
  • Jose M. Huerta Castano
  • Aurelio Barricarte Gurrea
  • Annika Idahl
  • Nina Ohlson
  • Eva Lundin
  • Karin Jirström
  • Elisabet Wirfält
  • Naomi E. Allen
  • Konstantinos K. Tsilidis
  • Kay-Tee Kaw
  • H. Bas Bueno-de-Mesquita
  • Vincent K. Dik
  • Sabina Rinaldi
  • Veronika Fedirko
  • Teresa Norat
  • Elio Riboli
  • Rudolf Kaaks
  • Petra H. M. Peeters
Show all

Summary, in English

Background: In 2007 the World Cancer Research Fund Report concluded that there was limited and inconsistent evidence for an effect of coffee and tea consumption on the risk of epithelial ovarian cancer (EOC). Objective: In the European Prospective Investigation into Cancer and Nutrition (EPIC), we aimed to investigate whether coffee intakes, tea intakes, or both are associated with the risk of EOC. Design: All women participating in the EPIC (n = 330,849) were included in this study. Data on coffee and tea consumption were collected through validated food-frequency questionnaires at baseline. HRs and 95% CIs were estimated by using Cox proportional hazards models. Furthermore, we performed an updated meta-analysis of all previous prospective studies until April 2011 by comparing the highest and lowest coffee- and tea-consumption categories as well as by using dose-response random-effects meta-regression analyses. Results: During a median follow-up of 11.7 y, 1244 women developed EOC. No association was observed between the risk of EOC and coffee consumption [HR: 1.05 (95% CI: 0.75, 1.46) for the top quintile compared with no intake] or tea consumption [HR: 1.07 (95% Cl: 0.78, 1.45) for the top quintile compared with no intake]. This lack of association between coffee and tea intake and EOC risk was confirmed by the results of our meta-analysis. Conclusion: Epidemiologic studies do not provide sufficient evidence to support an association between coffee and tea consumption and risk of ovarian cancer. Am J Clin Nutr 2012;95:1172-81.

Publishing year

2012

Language

English

Pages

1172-1181

Publication/Series

American Journal of Clinical Nutrition

Volume

95

Issue

5

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Nutrition and Dietetics

Status

Published

Research group

  • Nutrition Epidemiology

ISBN/ISSN/Other

  • ISSN: 1938-3207